269 related articles for article (PubMed ID: 19361546)
1. Effect of siRNA in PEG-coated siRNA-lipoplex on anti-PEG IgM production.
Tagami T; Nakamura K; Shimizu T; Ishida T; Kiwada H
J Control Release; 2009 Aug; 137(3):234-40. PubMed ID: 19361546
[TBL] [Abstract][Full Text] [Related]
2. B cell-intrinsic toll-like receptor 7 is responsible for the enhanced anti-PEG IgM production following injection of siRNA-containing PEGylated lipoplex in mice.
Hashimoto Y; Abu Lila AS; Shimizu T; Ishida T; Kiwada H
J Control Release; 2014 Jun; 184():1-8. PubMed ID: 24727075
[TBL] [Abstract][Full Text] [Related]
3. CpG motifs in pDNA-sequences increase anti-PEG IgM production induced by PEG-coated pDNA-lipoplexes.
Tagami T; Nakamura K; Shimizu T; Yamazaki N; Ishida T; Kiwada H
J Control Release; 2010 Mar; 142(2):160-6. PubMed ID: 19850094
[TBL] [Abstract][Full Text] [Related]
4. PEGylated liposomes elicit an anti-PEG IgM response in a T cell-independent manner.
Ishida T; Wang X; Shimizu T; Nawata K; Kiwada H
J Control Release; 2007 Oct; 122(3):349-55. PubMed ID: 17610982
[TBL] [Abstract][Full Text] [Related]
5. T cell-independent B cell response is responsible for ABC phenomenon induced by repeated injection of PEGylated liposomes.
Koide H; Asai T; Hatanaka K; Akai S; Ishii T; Kenjo E; Ishida T; Kiwada H; Tsukada H; Oku N
Int J Pharm; 2010 Jun; 392(1-2):218-23. PubMed ID: 20227473
[TBL] [Abstract][Full Text] [Related]
6. Anti-PEG IgM production by siRNA encapsulated in a PEGylated lipid nanocarrier is dependent on the sequence of the siRNA.
Tagami T; Uehara Y; Moriyoshi N; Ishida T; Kiwada H
J Control Release; 2011 Apr; 151(2):149-54. PubMed ID: 21223988
[TBL] [Abstract][Full Text] [Related]
7. Transport of PEGylated liposomes from the splenic marginal zone to the follicle in the induction phase of the accelerated blood clearance phenomenon.
Shimizu T; Ishida T; Kiwada H
Immunobiology; 2013 May; 218(5):725-32. PubMed ID: 22995937
[TBL] [Abstract][Full Text] [Related]
8. Application of polyglycerol coating to plasmid DNA lipoplex for the evasion of the accelerated blood clearance phenomenon in nucleic acid delivery.
Abu Lila AS; Uehara Y; Ishida T; Kiwada H
J Pharm Sci; 2014 Feb; 103(2):557-66. PubMed ID: 24347396
[TBL] [Abstract][Full Text] [Related]
9. Anti-PEG IgM production via a PEGylated nano-carrier system for nucleic acid delivery.
Ichihara M; Moriyoshi N; Lila AS; Ishida T; Kiwada H
Methods Mol Biol; 2013; 948():35-47. PubMed ID: 23070762
[TBL] [Abstract][Full Text] [Related]
10. Anti-PEG IgM elicited by injection of liposomes is involved in the enhanced blood clearance of a subsequent dose of PEGylated liposomes.
Wang X; Ishida T; Kiwada H
J Control Release; 2007 Jun; 119(2):236-44. PubMed ID: 17399838
[TBL] [Abstract][Full Text] [Related]
11. Hydrophobic blocks of PEG-conjugates play a significant role in the accelerated blood clearance (ABC) phenomenon.
Shiraishi K; Hamano M; Ma H; Kawano K; Maitani Y; Aoshi T; Ishii KJ; Yokoyama M
J Control Release; 2013 Feb; 165(3):183-90. PubMed ID: 23220106
[TBL] [Abstract][Full Text] [Related]
12. Spleen plays an important role in the induction of accelerated blood clearance of PEGylated liposomes.
Ishida T; Ichihara M; Wang X; Kiwada H
J Control Release; 2006 Oct; 115(3):243-50. PubMed ID: 17011060
[TBL] [Abstract][Full Text] [Related]
13. Activation of TLR9 by incorporated pDNA within PEG-coated lipoplex enhances anti-PEG IgM production.
Hashimoto Y; Uehara Y; Abu Lila AS; Ishida T; Kiwada H
Gene Ther; 2014 Jun; 21(6):593-8. PubMed ID: 24694537
[TBL] [Abstract][Full Text] [Related]
14. Pegfilgrastim (PEG-G-CSF) Induces Anti-polyethylene Glycol (PEG) IgM via a T Cell-Dependent Mechanism.
Elsadek NE; Emam SE; Abu Lila AS; Shimizu T; Ando H; Ishima Y; Ishida T
Biol Pharm Bull; 2020; 43(9):1393-1397. PubMed ID: 32879214
[TBL] [Abstract][Full Text] [Related]
15. Ex-vivo/in-vitro anti-polyethylene glycol (PEG) immunoglobulin M production from murine splenic B cells stimulated by PEGylated liposome.
Abu Lila AS; Ichihara M; Shimizu T; Ishida T; Kiwada H
Biol Pharm Bull; 2013; 36(11):1842-8. PubMed ID: 24189428
[TBL] [Abstract][Full Text] [Related]
16. Hemoglobin vesicles, polyethylene glycol (PEG)ylated liposomes developed as a red blood cell substitute, do not induce the accelerated blood clearance phenomenon in mice.
Taguchi K; Urata Y; Anraku M; Watanabe H; Kadowaki D; Sakai H; Horinouchi H; Kobayashi K; Tsuchida E; Maruyama T; Otagiri M
Drug Metab Dispos; 2009 Nov; 37(11):2197-203. PubMed ID: 19679674
[TBL] [Abstract][Full Text] [Related]
17. The co-delivery of oxaliplatin abrogates the immunogenic response to PEGylated siRNA-lipoplex.
Alaaeldin E; Abu Lila AS; Moriyoshi N; Sarhan HA; Ishida T; Khaled KA; Kiwada H
Pharm Res; 2013 Sep; 30(9):2344-54. PubMed ID: 23673556
[TBL] [Abstract][Full Text] [Related]
18. Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes.
Ishida T; Kiwada H
Int J Pharm; 2008 Apr; 354(1-2):56-62. PubMed ID: 18083313
[TBL] [Abstract][Full Text] [Related]
19. Anti-PEG IgM Is a Major Contributor to the Accelerated Blood Clearance of Polyethylene Glycol-Conjugated Protein.
Mima Y; Hashimoto Y; Shimizu T; Kiwada H; Ishida T
Mol Pharm; 2015 Jul; 12(7):2429-35. PubMed ID: 26070445
[TBL] [Abstract][Full Text] [Related]
20. Injection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomes.
Ishida T; Ichihara M; Wang X; Yamamoto K; Kimura J; Majima E; Kiwada H
J Control Release; 2006 May; 112(1):15-25. PubMed ID: 16515818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
